Cargando…
Tocilizumab: Bacterial and fungal infections during off label treatment: 2 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880030/ http://dx.doi.org/10.1007/s40278-021-91085-1 |
Ejemplares similares
-
Tocilizumab: Bacterial superinfection following off-label use: case report
Publicado: (2020) -
Tocilizumab: Off-label use and neutropenia: case report
Publicado: (2021) -
Tocilizumab: Herpes zoster infection following an off label use: case report
Publicado: (2022) -
Dexamethasone/tocilizumab: Lack of efficacy during off label use: case report
Publicado: (2022) -
Tocilizumab: Off label use and lack of efficacy: case report
Publicado: (2021)